Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vacci... Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0300001 | -0.36452126367 | 8.23 | 8.82 | 7.86 | 29153 | 8.3260979 | DE |
| 4 | 0.8199999 | 11.1111097561 | 7.38 | 8.82 | 7.28 | 31201 | 8.05326956 | DE |
| 12 | 1.0799999 | 15.1685379213 | 7.12 | 9.93 | 6.6 | 41344 | 8.1408715 | DE |
| 26 | 1.6679999 | 25.5358221066 | 6.532 | 10.128 | 6.184 | 42317 | 8.02449068 | DE |
| 52 | 2.5419999 | 44.9275344645 | 5.658 | 10.128 | 5.368 | 40672 | 7.48330128 | DE |
| 156 | 0.5979999 | 7.86634964483 | 7.602 | 24.96 | 3.313 | 60968 | 8.74784367 | DE |
| 260 | 0.5979999 | 7.86634964483 | 7.602 | 24.96 | 3.313 | 60968 | 8.74784367 | DE |
cojoboy
2分前
ihorchu
3分前
JohnnyRotton
12分前
atonal17
18分前
boston127
20分前
Hey_Its_That_Guy
24分前
Nemesis18
25分前
IronMan123
26分前
zerosnoop
27分前
Nemesis18
34分前
gdl
44分前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。